Main information

  • Trade name:
  • Calamari Oil 1000
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug



  • Available in:
  • Calamari Oil 1000
  • Language:
  • English

Other information


  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 219419
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:


Calamari Oil 1000

ARTG entry for

Medicine Listed


Australian Naturalcare Products Pty Ltd

Postal Address

PO Box 946,NORTH RYDE BC, NSW, 1670


ARTG Start Date


Product category




Approval area

Listed Medicines


Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be


The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.


1. Calamari Oil 1000

Product Type

Single Medicine Product

Effective date



Derived from seafood.

If symptoms persist consult your healthcare practitioner (or words to that effect).

Standard Indications

May assist peripheral circulation.

Aids or assists in the maintenance of peripheral circulation.

Temporary relief of the pain of arthritis. (or) Temporary relief of arthritic pain. [Warning S required]

May help reduce joint swelling associated with arthritis.

Aids, assists or helps in the maintenance or improvement of general well-being.

May assist in maintaining peripheral circulation and promoting general health.

Temporary relief of the pain of rheumatoid arthritis. [Warning S required]

May help reduce joint inflammation associated with arthritis.

Specific Indications

Supports brain health.

Supports eye health.

Supports the health of the retina of the eye.

DHA is a major structural component in the brain.

DHA is found in high concentrations in the cell membranes of cells in the brain and central nervous system.

DHA is needed for the maintenance of a normal healthy brain throughout life and is vital for normal brain development in the foetus and infant.

Helps support/maintain nervous system health.

Helps support/maintain nervous system function.

DHA comprises 30- 40% of the long-chain fatty acid content of the brain.

Higher intakes of DHA in the diet may be associated with better cognitive function in the elderly.

Supports/helps maintain healthy cognitive function.

Supports cognitive function as you age.

Supports healthy brain function.

(Studies suggest that) Low levels of DHA may be linked to poor memory function.

Public Summary

Page 1 of

Produced at 26.11.2017 at 03:43:03 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information

DHA is needed for brain development and cognitive function in infants/babies.

DHA is needed for healthy brain and eye development.

DHA is important in the normal healthy development of the brain, nervous system and retina/eye of the unborn child and growing infant.

DHA is essential for neural, visual, and cognitive development of a growing foetus.

Some research suggests that DHA may play a role in learning and memory function, as well as retinal and visual function.

The need for DHA significantly increases during the third trimester of pregnancy. During this time DHA rapidly accumulates in the brain of the developing

baby to facilitate rapid brain tissue growth and development.

Helps support heart and cardiovascular health.

Helps maintain normal/healthy triglyceride levels in healthy individuals.

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule


1. Formulation 1

Dosage Form

Capsule, soft

Route of Administration


Visual Identification

Active Ingredients

concentrated squid omega-3 triglycerides

1000 mg

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at

Public Summary

Page 2 of

Produced at 26.11.2017 at 03:43:03 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information